Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

oritavancin 400 MG Injection

Known as: ORITAVANCIN 400MG/VIL INJ, ORITAVANCIN 400MG/VIL INJ [VA Product], oritavancin (as oritavancin diphosphate) 400 MG Injection 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
The mode of action for desleucyl-oritavancin was investigated by adding an antibiotic to Staphylococcus aureus during its growth… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2017
2017
Gram-positive bacterial pathogens isolated from patient specimens submitted to 15 Canadian hospital laboratories from 2011 to… Expand
Is this relevant?
2014
2014
Gram-positive pathogens isolated in 15 Canadian hospital laboratories between 2011 and 2013 were tested for susceptibility to… Expand
  • table 1
  • table 1
  • figure 1
Is this relevant?
Highly Cited
2009
Highly Cited
2009
ABSTRACT Oritavancin activity was tested against 15,764 gram-positive isolates collected from 246 hospital centers in 25… Expand
  • table 1
  • table 2
Is this relevant?